Monday, February 24, 2025 | 03:53 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Neuland Labs zooms 53% in 7 days as net profit more-than-doubles in Q3

The change in business mix with increasing amount of margins coming from CMS business and certain Specialty products and cost optimization measures helped improve profitability

pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing
Premium

The strong performance during the quarter was driven by growth across the generic drug substances (GDS) and custom manufacturing solutions (CMS) verticals

SI Reporter Mumbai
Shares of Neuland Laboratories hit a fresh record high of Rs 1,965, up 16 per cent on the BSE, in the intra-day trade on Tuesday on the back of heavy volumes. In the past seven trading days, the stock of the pharmaceuticals company has soared 53 per cent after the company's net profit more-than-doubled at Rs 26.7 crore for the quarter ended December 2020 (Q3FY21) on the back of strong operational performance. It had reported a profit of Rs 11 crore in the year-ago quarter.

In Q3FY21, the company's Ebitda (earnings before interest, taxes, depreciation, and amortisation) jumped 60.6

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in